Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ADAP - Adaptimmune Therapeutics: Diverse Pipeline With Approval Looming

ADAP - Adaptimmune Therapeutics: Diverse Pipeline With Approval Looming

Adaptimmune Therapeutics plc
  • Adaptimmune Therapeutics has a diverse pipeline focused on TCR-engineered T cells.
  • Their most advanced candidate, afamitresgene autoleucel, will likely receive approval.
  • Current valuation is fair given their market cap and pipeline, but longer-term outlook remains bullish.

For further details see:

Adaptimmune Therapeutics: Diverse Pipeline With Approval Looming
Stock Information
Company Name: Adaptimmune Therapeutics plc
Stock Symbol: ADAP
Market: NASDAQ
Website: adaptimmune.com
Menu
ADAP ADAP Quote ADAP Short ADAP News ADAP Articles ADAP Message Board
Get ADAP Alerts

News, Short Squeeze, Breakout and More Instantly...